Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Measurement of endometrial thickness in premenopausal women in office gynecology.
Tsuda H, Ito YM, Todo Y, Iba T, Tasaka K, Sutou Y, Hirai K, Dozono K, Dobashi Y, Manabe M, Sakamoto T, Yamamoto R, Ueda K, Akatsuka M, Kiyozuka Y, Nagai N, Imai M, Kobiki K, Fujita H, Itamochi H, Oshita T, Kawarada T, Hatae M, Yokoyama Y. Tsuda H, et al. Among authors: hatae m. Reprod Med Biol. 2017 Sep 16;17(1):29-35. doi: 10.1002/rmb2.12062. eCollection 2018 Jan. Reprod Med Biol. 2017. PMID: 29371818 Free PMC article.
Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance.
Shimada M, Nishimura R, Nogawa T, Hatae M, Takehara K, Yamada H, Kurachi H, Yokoyama Y, Sugiyama T, Kigawa J. Shimada M, et al. Among authors: hatae m. Mol Clin Oncol. 2013 Jul;1(4):780-784. doi: 10.3892/mco.2013.112. Epub 2013 May 9. Mol Clin Oncol. 2013. PMID: 24649246 Free PMC article.
High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Fujiwara H, Masuzaki H, Katabuchi H, Kawakami Y, Okamoto A, Nogawa T, Matsumura N, Udagawa Y, Saito T, Itamochi H, Takano M, Miyagi E, Sudo T, Ushijima K, Iwase H, Seki H, Terao Y, Enomoto T, Mikami M, Akazawa K, Tsuda H, Moriya T, Tajima A, Inoue I, Tanaka K; Japanese Serous Ovarian Cancer Study Group. Yoshihara K, et al. Among authors: hatae m. Clin Cancer Res. 2012 Mar 1;18(5):1374-85. doi: 10.1158/1078-0432.CCR-11-2725. Epub 2012 Jan 12. Clin Cancer Res. 2012. PMID: 22241791
Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-based chemotherapy: a Phase II Study of the Japanese Gynecologic Oncology Group.
Katsumata N, Fujiwara Y, Kamura T, Nakanishi T, Hatae M, Aoki D, Tanaka K, Tsuda H, Kamiura S, Takehara K, Sugiyama T, Kigawa J, Fujiwara K, Ochiai K, Ishida R, Inagaki M, Noda K. Katsumata N, et al. Among authors: hatae m. Jpn J Clin Oncol. 2008 Nov;38(11):777-85. doi: 10.1093/jjco/hyn101. Epub 2008 Oct 16. Jpn J Clin Oncol. 2008. PMID: 18927230 Free PMC article. Clinical Trial.
Predicting time to ovarian carcinoma recurrence using protein markers.
Yang JY, Yoshihara K, Tanaka K, Hatae M, Masuzaki H, Itamochi H; Cancer Genome Atlas (TCGA) Research Network; Takano M, Ushijima K, Tanyi JL, Coukos G, Lu Y, Mills GB, Verhaak RG. Yang JY, et al. Among authors: hatae m. J Clin Invest. 2013 Sep;123(9):3740-50. doi: 10.1172/JCI68509. Epub 2013 Aug 15. J Clin Invest. 2013. PMID: 23945238 Free PMC article.
[Chemotherapy for cervical carcinoma].
Hatae M, Kanda E, Nakamura T, Yamamoto F, Ohnishi Y. Hatae M, et al. Gan To Kagaku Ryoho. 2005 Aug;32(8):1104-9. Gan To Kagaku Ryoho. 2005. PMID: 16121910 Review. Japanese.
Transplacental transmission of maternal B-cell lymphoma.
Maruko K, Maeda T, Kamitomo M, Hatae M, Sueyoshi K. Maruko K, et al. Among authors: hatae m. Am J Obstet Gynecol. 2004 Jul;191(1):380-1. doi: 10.1016/j.ajog.2003.12.036. Am J Obstet Gynecol. 2004. PMID: 15295401
86 results